Catherine Skari

COVID-19 & Haemoglobin Disorders: A Classification of Risk Groups & Other Considerations (2020)

A document seeking to offer a risk level classification for thalassaemia and SCD patients in relation to the ongoing COVID-19…

Read More »

FDA Grants RMAT Designation to CTX-001™ for the Treatment of Severe TDT β-Thalassaemia & SCD

CRISPR Therapeutics and Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX-001, an investigational, autologous, Gene Editing hematopoietic stem…

Read More »

TIF’s Latest Guide for the COVID-19 Pandemic is Going Public on the International Thalassaemia Day 2020

As the online celebrations for the International Thalassaemia Day 2020 are at their peak, TIF decided to publish today as a gift…

Read More »

Reblozyl (luspatercept-aamt) Receives Positive CHMP Opinion for the Treatment of Adults with β-Thalassaemia

On 30 April 2020, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of…

Read More »

The 1st TIF Webinar for Medical Specialists Scheduled for 11 May

  The 1st webinar for Medical Specialists organised in the context of TIF’s eThalEd online course has just arrived! Dr Antonio Piga,…

Read More »

TIF’s Global Call for Solidarity & Cooperation in support of WHO

  TIF expresses major concerns over the announcement of the United States to suspend financial support for the World Health Organisation…

Read More »

COVID-19: TIF Releases Position Statement on the Inclusion of Thalassaemia & SCD Patients in the High-Risk Population

The SARS-CoV-2 infection presents particular challenges and great risks to patients with thalassaemia and sickle cell disease (SCD) and, if…

Read More »

TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients

On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled ”Thalassaemia/SCD and COVID-19:…

Read More »

NOW ONLINE: TIF’s latest Informational Guide on Developing Vaccinations & Therapeutic Drugs for COVID-19

TIF has made an effort to put together a list of studies/clinical trials for treatments and vaccines about COVID-19, which…

Read More »

Developing Vaccinations & Therapeutic Drugs for COVID-19 (2020)

A list of studies/clinical trials for developing treatments and vaccines for the COVID-19 pandemic. This list is by no means…

Read More »